Male/female adults
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Men and women aged between 50 and 70 years at the time of consent acquisition. 2. Subjects who regularly consume three solid meals per day. 3. Subjects who can consume four sticks of a load meal (Calorie Mate) in a single sitting. 4. Subjects who are able to participate in a test involving an overnight stay of 1 night and 2 days. 5. Subjects who can give informed consent to partake in this study, after being provided with an explanation of the protocol detail.
Exclusion criteria
Exclusion criteria: 1. Subjects who are taking medications (related to diabetes, gastrointestinal organs, or metabolism) more than twice a week, which may potentially affect the trial, and cannot restrict their use during the study period. 2. Subjects with dislikes or allergies to the ingredients of the test food. 3. Subjects with previous and/or current medical history of diabetes. 4. Subjects with previous and/or current medical history of gastrointestinal diseases and/or surgery. 5. Subjects with current immune diseases and/or those taking related medications. 6. Subjects who are participating in the other clinical trials and/or who have participated in the other clinical trials within 4 weeks prior to the current trial and/or who are planning to participate in the other clinical trials. 7. Subjects with previous and/or current medical history of serious diseases in heart, liver, kidney and/or digestive organs. 8. Subjects who are pregnant, breastfeeding, or intending to become pregnant during trial period. 9. Subjects with allergies to medications and/or food. 10. Subjects deemed unsuitable for participation in the trial by the principal investigator or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Four items related to appetite (Visual Analogue Scale, VAS) | — |
Secondary
| Measure | Time frame |
|---|---|
| Four items regarding craving for specific foods (Visual Analogue Scale, VAS) One item related to spiciness (likert scale) | — |
Countries
Japan
Contacts
Seisyukai Clinic, Seishukai Medical corporation Clinical trial division